Investigate Now: Loblaw's deal to limit Medication Access

Corporate Giants are forcing you to buy your medication on their terms. Help us keep corporate control out of your medicine cabinet.

You should be able to choose where you buy your medication. The NDP is requesting that the Competition Bureau conduct a formal investigation into the exclusive arrangement between Loblaw and Manulife.

    Manulife, the biggest insurance company in Canada, has recently announced that the medications covered under their Special Drug Care program will primarily be delivered through Loblaw, the biggest grocery and retail chain in Canada.

    The arrangement between these two corporate giants will affect approximately 260 medications, including those used for treating conditions such as rheumatoid arthritis, Crohn's, multiple sclerosis, pulmonary arterial hypertension, cancer, osteoporosis, and hepatitis C.

    Once again, the Liberals are letting Loblaws make deals to boost their profits while people are already struggling to buy medications and groceries.

    New Democrats stand firmly against this blatant corporate greed, and are calling on the Competition Bureau of Canada to investigate this arrangement. Affordable access to prescription drugs should be protected and expanded.

    Galen Weston and Manulife should not be allowed to restrict your access to essential medications. Stand with Jagmeet in taking action against corporate greed and confronting corporate control in Ottawa.

    Help spread the word

    Thank you for your support.

    Take the next step and help spread the word.

    Thanks for taking the time to be a part of our work on the issues that matter to people! When you submit your email and phone number, you are consenting to receive text messages, emails, and calls from Jagmeet Singh and Canada's NDP team. Message frequency will vary and message and data rates may apply. You can always text HELP for more information or STOP to stop receiving messages. And you can unsubscribe from emails at any time. Want to know more? See our full privacy policy here.